Clinical Trials

Showing trials with last updates posted in 2025.

NCT04232085 | RECRUITING | PHASE2
27 participants

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-28
Start Date:
2020-02-12
Completion:
2027-12-31
Conditions
  • Primary Immune Deficiency Disorder
  • Immune Deficiency Disease
  • Bone Marrow Failure
  • Short Telomere Length
  • Fanconi Anemia
  • Non Fanconi DNA-DSB Repair Disorder
  • Hoyeraal-Hreidarsson Syndrome
  • Dyskeratosis Congenita
  • Telomere Biology Disorder
  • Short Telomere Syndrome
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT03983954 | ACTIVE_NOT_RECRUITING | PHASE1
120 participants

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-28
Start Date:
2019-10-10
Completion:
2027-03-01
Conditions
  • ER+ Breast Cancer
  • Ovarian Cancer
  • Cervical Squamous Cell Carcinoma
  • Pancreatic Adenocarcinoma
  • Endometrial Cancer
  • Renal Cell Carcinoma
  • Urothelial Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Mesothelioma
  • Melanoma
  • Hepatocellular Carcinoma
  • Prostate Cancer
  • NSCLC
  • HER2-negative Breast Cancer
  • Triple Negative Breast Cancer
  • Bladder Cancer
  • Colorectal Cancer Metastatic
  • GastroEsophageal Cancer
  • NSCL2 Gene Mutation
  • Esophageal Cancer
Interventions
  • COMBINATION_PRODUCT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page